Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2016, Article ID 6462804, 4 pages
http://dx.doi.org/10.1155/2016/6462804
Research Article

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions

1Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan 8187698191, Iran
2Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran 1937957514, Iran
3Department of Dermatology, Isfahan University of Medical Sciences, Isfahan 8174675731, Iran

Received 11 November 2015; Revised 14 March 2016; Accepted 30 March 2016

Academic Editor: Bruno A. Bernard

Copyright © 2016 Fariba Jaffary et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Choi and E. A. Lerner, “Leishmaniasis as an emerging infection,” Journal of Investigative Dermatology Symposium Proceedings, vol. 6, no. 3, pp. 175–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Nilforoushzadeh, F. Jaffary, S. Moradi, R. Derakhshan, and E. Haftbaradaran, “Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis,” BMC Complementary and Alternative Medicine, vol. 7, article 13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kassi, A. K. Afghan, R. Rehman, P. M. Kasi, and M. Kassi, “Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan,” PLoS Neglected Tropical Diseases, vol. 2, no. 10, article e259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Reithinger, J.-C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker, “Cutaneous leishmaniasis,” The Lancet Infectious Diseases, vol. 7, no. 9, pp. 581–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. V. Piscopo and C. Mallia Azzopardi, “Leishmaniasis,” Postgraduate Medical Journal, vol. 83, no. 976, pp. 649–657, 2007. View at Google Scholar · View at Scopus
  6. Y. Dowlati, “Cutaneous leishmaniasis: clinical aspect,” Clinics in Dermatology, vol. 14, no. 5, pp. 425–431, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Arevalo, B. Ward, R. Miller et al., “Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator,” Clinical Infectious Diseases, vol. 33, no. 11, pp. 1847–1851, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ghosh, K. Roy, and S. Roy, “Immunomodulatory effects of antileishmanial drugs,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 12, pp. 2834–2838, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Committee for Guidelines of Care for Chemical Peeling, “Guidelines for chemical peeling in Japan (3rd edition),” The Journal of Dermatology, vol. 39, no. 4, pp. 321–325, 2012. View at Google Scholar
  10. T. H. Nguyen and J. A. Rooney, “Trichloroacetic acid peels,” Dermatologic Therapy, vol. 13, no. 2, pp. 173–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kimura, N. Kanazawa, H.-J. Li, N. Yonei, Y. Yamamoto, and F. Furukawa, “Influence of chemical peeling on the skin stress response system,” Experimental Dermatology, vol. 21, supplement 1, pp. 8–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Siadat, F. Jaffary, M. Nilforoushzadeh, N. Ansari, and S. Moradi, “The comparison between trichloroacetic acid 50% and CO2 laser in the treatment of cutaneous leishmaniasis scar,” Indian Journal of Dermatology, vol. 56, no. 2, pp. 171–173, 2011. View at Publisher · View at Google Scholar
  13. M. A. Nilforoushzadeh, F. Fatemi Naieni, N. Sattar, E. Haftbaradaran, F. Jaffary, and G. H. Askari, “The efficacy of intralesional meglumine antimoniate (glucantime) versus a combination of topical trichloroacetic acid 50% and local heat therapy by non-ablative radiofrequency on cutaneous leishmaniasis lesions,” Journal of Research in Medical Sciences, no. 1, pp. s97–s102, 2012. View at Google Scholar
  14. N. Saedi, H. R. Jalian, A. Petelin, and C. Zachary, “Fractionation: past, present, future,” Seminars in Cutaneous Medicine and Surgery, vol. 31, no. 2, pp. 105–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lapidoth, S. Halachmi, S. Cohen, and D. B. Amitai, “Fractional CO2 laser in the treatment of facial scars in children,” Lasers in Medical Science, vol. 29, no. 2, pp. 855–857, 2014. View at Publisher · View at Google Scholar
  16. K. M. Alghamdi, “Successful treatment of atrophic scars from cutaneous leishmaniasis using a fractional laser,” Journal of Cutaneous Medicine and Surgery, vol. 14, no. 6, pp. 303–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Nilforoushzadeh, S. H. Minaravesh, F. Jaffary, A. H. Siadat, and E. Haftbaradaran, “Comparison the efficacy of ablative CO2 laser and fractional CO2 laser on the healing of cutaneous leishmaniasis scars,” Advanced Biomedical Research, vol. 3, article 259, 2014. View at Publisher · View at Google Scholar
  18. J. Alvar, I. D. Vélez, C. Bern et al., “Leishmaniasis worldwide and global estimates of its incidence,” PLoS ONE, vol. 7, no. 5, Article ID e35671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Karami, M. Doudi, and M. Setorki, “Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran,” Journal of Vector Borne Diseases, vol. 50, no. 1, pp. 30–37, 2013. View at Google Scholar · View at Scopus
  20. U. González, M. Pinart, L. Reveiz, and J. Alvar, “Interventions for old world cutaneous leishmaniasis,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD005067, 2008. View at Google Scholar · View at Scopus
  21. R. Hadighi, M. Mohebali, P. Boucher, H. Hajjaran, A. Khamesipour, and M. Ouellette, “Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites,” PLoS Medicine, vol. 3, no. 5, article e162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Nilforoushzadeh, F. Jaffary, N. Ansari, S. Moradi, and A. H. Siadat, “The comparison between trichloroacetic acid 50% and CO2 laser in the treatment of cutaneous leishmaniasis scar,” Indian Journal of Dermatology, vol. 56, no. 2, pp. 171–173, 2011. View at Publisher · View at Google Scholar
  23. N. M. Ali, J. Fariba, H. Elaheh, and N. Ali, “The efficacy of 5% trichloroacetic acid cream in the treatment of cutaneous leishmaniasis lesions,” Journal of Dermatological Treatment, vol. 23, no. 2, pp. 136–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Asilian, A. Sharif, G. Faghihi, S. Enshaeieh, F. Shariati, and A. H. Siadat, “Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis,” International Journal of Dermatology, vol. 43, no. 10, pp. 736–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Shamsi Meymandi, S. Zandi, H. Aghaie, and A. Heshmatkhah, “Efficacy of CO2 laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 5, pp. 587–591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. B. Babajev, O. G. Babajev, and V. I. Korepanov, “Treatment of cutaneous leishmaniasis using a carbon dioxide laser,” Bulletin of the World Health Organization, vol. 69, no. 1, pp. 103–106, 1991. View at Google Scholar · View at Scopus